Capital Design Thousand Oaks Venture Capital 
socalTECH
DECEMBER 19, 2018
Thousand Oaks-based Amgen and Swiss biotech company Molecular Partners AG said Tuesday that the two are in a collaboration and licensing deal, for the commercialization of a molecule aimed at the immuno-oncology area.
socalTECH
JULY 8, 2010
Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. switchgrass and high-biomass sorghum--which are specifically designed to maximize the energy output of biofuels. Ceres is developing improved seed varieties--including.
Expert insights. Personalized for you.
113 
Let's personalize your content